These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21767104)

  • 1. Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood.
    Bellissima V; Visser GH; Ververs TF; van Bel F; Termote JU; van der Heide M; Florio P; Li Volti G; Gazzolo D
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():31-4. PubMed ID: 21767104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal Maternal Antidepressants Drugs Affect S100B Concentrations in Fetal-Maternal Biological Fluids.
    Bellissima V; Visser GH; Ververs TF; Bel Fv; Termote JU; Heide Mv; Gazzolo D
    CNS Neurol Disord Drug Targets; 2015; 14(1):49-54. PubMed ID: 25613501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy exposure to citalopram - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood.
    Paulzen M; Goecke TW; Stingl JC; Janssen G; Stickeler E; Gründer G; Schoretsanitis G
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):213-219. PubMed ID: 28663113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological and regulatory roles of activin A in late pregnancy.
    Jenkin G; Ward J; Loose J; Schneider-Kolsky M; Young R; Canny B; O'Connor A; de Kretser D; Wallace E
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):131-8. PubMed ID: 11451582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal maternal antidepressants drugs treatment affects S100B levels in maternal-fetal biological fluids in a dose dependent manner.
    Bellissima V; Visser GHA; Ververs T; Pluchinotta F; Varrica A; Baryshnikova E; Gabriella Tina L; Nigro F; Gavilanes D; Godos J; Gazzolo D
    Clin Chim Acta; 2020 Feb; 501():20-26. PubMed ID: 31809746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis.
    Schoretsanitis G; Westin AA; Stingl JC; Deligiannidis KM; Paulzen M; Spigset O
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110228. PubMed ID: 33358964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
    Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy: An Observational Study.
    Pogliani L; Falvella FS; Cattaneo D; Pileri P; Moscatiello AF; Cheli S; Baldelli S; Fabiano V; Cetin I; Clementi E; Zuccotti G
    Ther Drug Monit; 2017 Apr; 39(2):197-201. PubMed ID: 28045861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertraline in pregnancy - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood.
    Paulzen M; Goecke TW; Stickeler E; Gründer G; Schoretsanitis G
    J Affect Disord; 2017 Apr; 212():1-6. PubMed ID: 28129551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fetal activin A in labor complicated by meconium-stained amniotic fluid].
    Redźko S; Przepieść J; Zelazowska B; Zak J; Wysocka J; Urban J
    Ginekol Pol; 2007 Aug; 78(8):621-5. PubMed ID: 18050611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid.
    Fokina VM; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN
    Am J Obstet Gynecol; 2016 Oct; 215(4):497.e1-7. PubMed ID: 27180885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy exposure to quetiapine - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes.
    Paulzen M; Goecke TW; Kuzin M; Augustin M; Gründer G; Schoretsanitis G
    Schizophr Res; 2018 May; 195():252-257. PubMed ID: 28965779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo concentrations of inhibins, activin A and follistatin in human early pregnancy.
    Muttukrishna S; Jauniaux E; McGarrigle H; Groome N; Rodeck CH
    Reprod Biomed Online; 2004 Jun; 8(6):712-9. PubMed ID: 15169590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of graded hypoxia on activin A, prostaglandin E2 and cortisol levels in the late-pregnant sheep.
    Supramaniam VG; Jenkin G; Wallace EM; O'Connor AE; de Kretser DM; Miller SL
    Reprod Fertil Dev; 2004; 16(6):625-32. PubMed ID: 15740685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
    Laine K; Heikkinen T; Ekblad U; Kero P
    Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death.
    Petraglia F; Gomez R; Luisi S; Florio P; Tolosa JE; Stomati M; Romero R
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):194-7. PubMed ID: 9914603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.
    Nordeng H; Spigset O
    Drug Saf; 2005; 28(7):565-81. PubMed ID: 15963005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
    Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.